Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Analysis 2012-2017 and Forecast 2018-2023

Report ID: PR7419 Category: Pages: 101 99Strategy

$3,300$6,600

Clear

Snapshot
The Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Chemotherapy-Induced Nausea and Vomiting Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy’s Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
China
Japan & Korea
India
Southeast Asia
Oceania

Report ID: PR7419 Category: Pages: 101 99Strategy

Table of Content
1 Industry Overview
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry
1.1.1 Overview
1.1.2 Development of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Market Segment
1.2.1 By Product Type
1.2.2 By Application
1.3 Asia-Pacific Overview
2 Major Companies List
2.1 Merck & Co., Inc. (Company Profile, Products & Services, Sales Data etc.)
2.2 GlaxoSmithKline plc (Company Profile, Products & Services, Sales Data etc.)
2.3 Tesaro, Inc. (Company Profile, Products & Services, Sales Data etc.)
2.4 Helsinn Group (Company Profile, Products & Services, Sales Data etc.)
2.5 F. Hoffmann-La Roche Ltd. (Company Profile, Products & Services, Sales Data etc.)
2.6 Heron Therapeutics, Inc. (Company Profile, Products & Services, Sales Data etc.)
2.7 Dr. Reddy’s Laboratories Ltd. (Company Profile, Products & Services, Sales Data etc.)
2.8 Acacia Pharma (Company Profile, Products & Services, Sales Data etc.)
2.9 Sun Pharmaceutical Industry Ltd. (Company Profile, Products & Services, Sales Data etc.)
2.10 Otsuka Holdings Co., Ltd. (Company Profile, Products & Services, Sales Data etc.)
3 Market Competition
3.1 Company Competition
3.2 Regional Market by Company
4 Chemotherapy-Induced Nausea and Vomiting Drugs Market by Type
4.1 By Type
4.1.1 Existing Drugs
4.1.2 Akynzeo (Netupitant-Palonosetron FDC)
4.1.3 Aloxi (Palonosetron)
4.1.4 Emend (Aprepitant)
4.1.5 Kytril Generic (Granisetron)
4.1.6 Zofran Generic (Ondansetron)
4.1.7 Pipeline Drugs
4.1.8 SUSTOL (Granisetron Injection extended release)
4.1.9 Rolapitant
4.2 Market Size
4.3 Market Forecast
5 Market Demand
5.1 Demand Situation
5.1.1 Demand in Serotonin Receptor Antagonists
5.1.2 Demand in NK1 Receptor Antagonists
5.2 Regional Demand Comparison
5.3 Demand Forecast
6 Region Operation
6.1 Regional Production
6.2 Regional Market
6.3 by Region
6.3.1 China
6.3.1.1 By Type
6.3.1.2 By Application
6.3.2 Japan & Korea
6.3.2.1 By Type
6.3.2.2 By Application
6.3.3 India
6.3.3.1 By Type
6.3.3.2 By Application
6.3.4 Southeast Asia
6.3.4.1 By Type
6.3.4.2 By Application
6.3.5 Oceania
6.3.5.1 By Type
6.3.5.2 By Application
6.4 Regional Forecast
7 Marketing & Price
7.1 Price and Margin
7.1.1 Price Trends
7.1.2 Factors of Price Change
7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel
8 Upstream & Cost
8.1 Upstream
8.2 Cost
9 Industry Environment
9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology
10 Research Conclusion

Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Structure
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth Rate 2012-2023
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Company, in 2018
Figure Japan & Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Company, in 2018
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Company, in 2018
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Company, in 2018
Figure Oceania Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Company, in 2018
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Growth 2012-2017, by Type, in Volume
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in USD Million
Figure China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in Volume
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in USD Million
Figure India Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in Volume
Figure Oceania Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in USD Million
Figure Oceania Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview